Atara Biotherapeutics reported a gross margin of 69.68% and a net margin of -767.30% for the quarter ended Jun 2026. These financial ratios cover 47 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 82.38% | -202.51% | -22.31% | 25.68% | 92.74% | 83.84% | 81.08% | 79.25% | 79.18% | 96.85% | 96.67% | 93.48% | 75.97% | 69.68% | |||||||||||||||||||||||||||||
| EBT Margin | -1,576.61% | -1,239.07% | -1,204.61% | 35.80% | -1,885.65% | -30,110.89% | -6,096.98% | -7,430.20% | -3,265.48% | -1,427.28% | -115.98% | -66.51% | -54.56% | -38.81% | 38.73% | 13.60% | -123.81% | -212.41% | -803.29% | -767.14% | |||||||||||||||||||||||||||
| EBIT Margin | -1,579.37% | -1,237.45% | -1,206.18% | -62.30% | -1,897.78% | -30,459.27% | -6,118.92% | -7,462.28% | -3,255.94% | -1,410.21% | -114.22% | -63.66% | -54.14% | -37.26% | 39.53% | 18.19% | -103.50% | -160.69% | -652.91% | -749.21% | |||||||||||||||||||||||||||
| EBITDA Margin | -1,579.37% | -1,237.45% | -1,206.18% | -62.30% | -1,897.78% | -30,459.27% | -6,118.92% | -7,462.28% | -3,255.94% | -1,410.21% | -114.22% | -63.66% | -54.14% | -37.26% | 39.53% | 18.19% | -103.50% | -160.69% | -652.91% | -749.21% | |||||||||||||||||||||||||||
| Operating Margin | -1,579.37% | -1,237.45% | -1,206.18% | -62.30% | -1,897.78% | -30,459.27% | -6,118.92% | -7,462.28% | -3,255.94% | -1,410.21% | -114.22% | -63.66% | -54.14% | -37.26% | 39.53% | 18.19% | -103.50% | -160.69% | -652.91% | -749.21% | |||||||||||||||||||||||||||
| Net Margin | -1,576.61% | -1,239.47% | -1,204.61% | 35.80% | -1,885.87% | -30,111.69% | -6,098.78% | -7,430.30% | -3,264.59% | -1,427.54% | -116.07% | -66.51% | -54.51% | -38.75% | 38.73% | 13.58% | -124.62% | -641.25% | -803.29% | -767.30% | |||||||||||||||||||||||||||
| FCF Margin | -1,170.09% | -486.69% | -1,191.33% | -126.76% | -1,461.96% | -22,950.40% | -3,167.05% | -5,568.97% | -2,414.73% | -1,186.50% | -108.71% | -37.27% | -9.93% | -74.99% | -28.67% | -41.64% | -283.43% | -357.18% | -595.54% | -529.84% | |||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 3.46M | 6.60M | 7.23M | 8.15M | 12.89M | 17.42M | 16.36M | 12.32M | |||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 453.36M | 459.02M | 432.70M | 416.70M | 402.22M | 372.37M | 339.25M | 274.26M | 217.61M | 177.15M | 165.39M | 141.28M | 130.00M | 125.90M | 85.57M | 49.47M | 33.53M | 25.20M | 20.12M | 20.51M | |||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.03 | 0.04 | 0.06 | 0.17 | 0.18 | 0.17 | 0.17 | 0.03 | 0.02 | 0.05 | 0.21 | 0.44 | 0.77 | 1.02 | 2.33 | 3.81 | 4.53 | 4.79 | 1.15 | 0.30 | |||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -0.02M | -249.09 | -687.98 | -645.63 | -56.15 | -51.82 | -49.90 | -50.99 | -27.10 | -14.45 | -18.39 | -12.00 | 38.15 | 3.29 | -3.93 | -2.87 | -4.06 | -24.71 | |||||||||||||||||||||||||||||
| Times Interest Earned | -0.02M | -249.09 | -687.98 | -645.63 | -56.15 | -51.82 | -49.90 | -50.99 | -27.10 | -14.45 | -18.39 | -12.00 | 38.15 | 3.29 | -3.93 | -2.87 | -4.06 | -24.71 | |||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -18.69 | -15.44 | -9.85 | 39.80 | -4.26 | -4.21 | -3.74 | -2.29 | -2.16 | -0.90 | -2.63 | -2.74 | -2.77 | -7.85 | 1.68 | 39.45 | -45.17 | -22.19 | -16.07 | -35.70 | |||||||||||||||||||||||||||
| Price to SalesP/S | 294.62 | 191.41 | 118.64 | 14.25 | 80.43 | 0.00M | 228.35 | 170.09 | 70.55 | 12.84 | 3.05 | 1.82 | 1.51 | 3.04 | 0.65 | 5.36 | 56.29 | 142.27 | 129.08 | 273.93 | |||||||||||||||||||||||||||
| Price to BookP/B | 5.10 | 5.17 | 3.87 | 2.85 | 1.92 | 2.48 | 4.31 | 21.84 | -2.97 | 0.55 | -0.85 | -0.47 | -0.67 | -1.02 | 0.13 | -2.69 | -5.31 | -5.89 | -1.79 | -4.66 | |||||||||||||||||||||||||||
| Enterprise Value | 1,224.88M | 1,073.67M | 565.93M | 403.72M | 93.24M | 71.82M | 74.55M | 9.13M | 48.44M | 2.86M | 37.27M | 16.92M | -6.49M | 57.17M | 49.95M | 71.84M | 180.66M | 218.42M | 58.20M | 156.03M | |||||||||||||||||||||||||||
| EV to EBIT | -14.44 | -11.49 | -6.41 | -12.56 | -1.10 | -0.95 | -0.99 | -0.13 | -0.70 | -0.05 | -1.19 | -0.93 | 0.30 | -4.68 | 1.29 | 22.47 | -50.55 | -85.22 | -17.28 | -33.06 | |||||||||||||||||||||||||||
| EV to EBITDA | -14.44 | -11.49 | -6.41 | -12.56 | -1.10 | -0.95 | -0.99 | -0.13 | -0.70 | -0.05 | -1.19 | -0.93 | 0.30 | -4.68 | 1.29 | 22.47 | -50.55 | -85.22 | -17.28 | -33.06 | |||||||||||||||||||||||||||
| Market Capitalization | 1,582.13M | 1,444.73M | 867.74M | 735.03M | 358.64M | 314.64M | 279.96M | 162.77M | 150.84M | 54.59M | 83.51M | 52.22M | 60.70M | 99.67M | 63.94M | 94.16M | 194.37M | 226.92M | 66.60M | 172.58M | |||||||||||||||||||||||||||
| Price to FCFP/FCF | -25.18 | -39.33 | -9.96 | -11.24 | -5.50 | -5.53 | -7.21 | -3.05 | -2.92 | -1.08 | -2.81 | -4.89 | -15.22 | -4.06 | -2.27 | -12.87 | -19.86 | -39.83 | -21.67 | -51.70 | |||||||||||||||||||||||||||
| EV to FCF | -19.49 | -29.23 | -6.49 | -6.17 | -1.43 | -1.26 | -1.92 | -0.17 | -0.94 | -0.06 | -1.25 | -1.59 | 1.63 | -2.33 | -1.78 | -9.82 | -18.46 | -38.34 | -18.94 | -46.74 | |||||||||||||||||||||||||||
| EV to CFO | -20.77 | -31.33 | -6.70 | -6.31 | -1.43 | -1.26 | -1.94 | -0.17 | -0.94 | -0.06 | -1.26 | -1.59 | 1.63 | -2.34 | -1.78 | -9.82 | -18.46 | -38.34 | -18.94 | -46.74 | |||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -1,579.37% | -1,237.45% | -1,206.18% | -62.30% | -1,897.78% | -30,459.27% | -6,118.92% | -7,462.28% | -3,255.94% | -1,410.21% | -114.22% | -63.66% | -54.14% | -37.26% | 39.53% | 18.19% | -103.50% | -160.69% | -652.91% | -749.21% | |||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -89.53% | -96.38% | -105.83% | -85.06% | -90.42% | -95.59% | -98.50% | -153.52% | -210.49% | -790.40% | 1,517.68% | 2,561.91% | 504.91% | 962.15% | -35.54% | 23.03% | 169.42% | 348.89% | -43.60% | -104.12% | |||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -72.40% | -74.15% | -80.91% | -59.48% | -61.48% | -61.34% | -63.40% | -111.08% | -133.43% | -156.02% | -141.10% | -128.33% | -102.63% | -67.83% | -18.28% | 11.71% | 69.78% | 102.64% | -80.98% | -114.62% |